Literature DB >> 27503491

The Role of Laparoscopic Radical Hysterectomy in Early-Stage Adenocarcinoma of the Uterine Cervix.

Jeong-Yeol Park1, Daeyeon Kim1, Dae-Shik Suh1, Jong-Hyeok Kim1, Yong-Man Kim1, Young-Tak Kim1, Joo-Hyun Nam2.   

Abstract

OBJECTIVE: To compare long-term survival outcomes and patterns of recurrence of laparoscopic radical hysterectomy (LRH) and open radical hysterectomy (ORH) in early-stage cervical adenocarcinoma.
METHODS: The medical records of 293 patients with stage IA2-IIA cervical adenocarcinomas who underwent radical hysterectomy were retrospectively reviewed.
RESULTS: In total, 186 patients underwent LRH and 107 underwent ORH. There was no difference between the two surgery groups in clinicopathologic characteristics. There were no differences in disease-free survival (DFS) and overall survival (OS) between the LRH and ORH groups (88.7 vs. 84.1 %, P = 0.725; and 93.0 vs. 86.9 %, P = 0.735) for univariate analysis and multivariate analysis after adjusting for other significant prognostic factors. There was no difference in the patterns of recurrence between the two surgery groups (P = 0.220). The median time interval between surgery and the first recurrence were 25 months (range, 3-100 months) for LRH group and 14 months (range, 3-128 months) for ORH group (P = 0.230). The LRH group showed significantly fewer postoperative complications (P < 0.001), less estimated blood loss (P < 0.001), faster bowel movement recovery (P < 0.001), shorter postoperative hospital stay (P < 0.001), and a lower rate of wound dehiscence, ileus, lymphedema, infected lymphocele, and pelvic abscess (P = 0.004, 0.011, 0.017, and 0.040, respectively).
CONCLUSIONS: LRH has comparable survival outcomes with ORH and did not affect the pattern of recurrence in early-stage adenocarcinoma of the uterine cervix. The surgical outcomes were more favorable than ORH.

Entities:  

Mesh:

Year:  2016        PMID: 27503491     DOI: 10.1245/s10434-016-5489-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  6 in total

1.  A Comparison of Laparoscopies and Laparotomies for Radical Hysterectomy in Stage IA1-IB1 Cervical Cancer Patients: A Single Team With 18 Years of Experience.

Authors:  Meng Qin; Li Siyi; Hui-Fang Huang; Yan Li; Yu Gu; Wei Wang; Ying Shan; Jie Yin; Yong-Xue Wang; Yan Cai; Jia-Yu Chen; Ying Jin; Ling-Ya Pan
Journal:  Front Oncol       Date:  2020-08-28       Impact factor: 6.244

2.  Factors Associated with Patient Survival in Clear Cell Adenocarcinoma of the Cervix: A Single-Center Experience in China.

Authors:  Ting Wang; Zhiying Lu; Xiaodan Zhang; Keqin Hua
Journal:  Int J Gen Med       Date:  2022-05-03

3.  Retrospective Comparison of Laparoscopic versus Open Radical Hysterectomy for Early-Stage Cervical Cancer in a Single Tertiary Care Institution from Lithuania between 2009 and 2019.

Authors:  Danuta Vasilevska; Dominika Vasilevska; Andrzej Semczuk; Vilius Rudaitis
Journal:  Medicina (Kaunas)       Date:  2022-04-17       Impact factor: 2.430

Review 4.  Protective operative techniques in radical hysterectomy in early cervical carcinoma and their influence on disease-free and overall survival: a systematic review and meta-analysis of risk groups.

Authors:  Johanna Kampers; E Gerhardt; P Sibbertsen; T Flock; R Klapdor; H Hertel; M Jentschke; P Hillemanns
Journal:  Arch Gynecol Obstet       Date:  2021-05-22       Impact factor: 2.344

5.  Comparison of Minimally Invasive Versus Abdominal Radical Hysterectomy for Early-Stage Cervical Cancer: An Updated Meta-Analysis.

Authors:  Mengting Zhang; Wei Dai; Yuexiu Si; Yetan Shi; Xiangyuan Li; Ke Jiang; Jingyi Shen; Liying Ying
Journal:  Front Oncol       Date:  2022-01-24       Impact factor: 6.244

Review 6.  Perioperative morbidity of different operative approaches in early cervical carcinoma: a systematic review and meta-analysis comparing minimally invasive versus open radical hysterectomy.

Authors:  J Kampers; E Gerhardt; P Sibbertsen; T Flock; H Hertel; R Klapdor; M Jentschke; P Hillemanns
Journal:  Arch Gynecol Obstet       Date:  2021-10-08       Impact factor: 2.493

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.